4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glabridin is an active ingredient extracted from the root of Glycyrrhiza glabra. Previous studies showed that glabridin had potent hepatoprotective effect, however, the effect of glabridin on liver fibrosis and its potential mechanisms remain largely unknown. The present study was aimed to study the effect and potential mechanisms of glabridin on liver fibrosis in carbon tetrachloride (CCl4)-treated mouse livers. Glabridin attenuated the liver injury and improved pathological changes in CCl4-treated mouse livers. Glabridin suppressed the liver fibrosis in CCl4-treated mouse livers, as shown by the decreased collagen deposition, the reduced hydroxyproline level together with the decreased mRNA and protein expression of α-SMA, fibronectin and α1(I)procollagen in mouse livers. Interestingly, glabridin increased the mRNA and protein expression of proliferator-activated receptor gamma (PPARγ) in CCl4-treated mouse livers. In addition, both immunohistochemistry and tissue immunofluorescence showed that glabridin upregulated the expression of PPARγ in CCl4-treated mouse livers. Glabridin evidently reduced the levels of pro-inflammatory factors and increased the level of anti-inflammatory factor in CCl4-treated mouse livers and sera. In addition, Glabridin inhibited the level of MDA and increased the level of GSH as well as the total antioxidant capacity (T-AOC) in CCl4-treated mouse livers. In vitro study showed that glabridin reduced the cell viability of PDGF-BB-stimulated JS-1 cells. Noteworthy, glabridin showed no obvious toxicity on normal JS1 cells. Glabridin inhibited the protein expression of α-SMA, fibronectin and α1(I)procollagen, and increased the expression of PPARγ in stimulated JS-1 cells. Furthermore, disruption of PPARγ attenuated the anti-inflammatory and anti-oxidative stress effects of glabridin in stimulated JS-1 cells. Collectively, glabridin inhibited the liver fibrosis and hepatic stellate cells activation by suppressing inflammation and oxidative stress through activation of PPARγ in carbon tetrachloride-treated mice.

          Related collections

          Author and article information

          Journal
          Int Immunopharmacol
          International immunopharmacology
          Elsevier BV
          1878-1705
          1567-5769
          Dec 2022
          : 113
          : Pt B
          Affiliations
          [1 ] Department of Pharmacy, Affiliated Matern &Child Care Hospital of Nantong University, No. 399 Century Avenue, Nantong 226018, China.
          [2 ] Department of Infectious Diseases, Affiliated Matern &Child Care Hospital of Nantong University, No. 399 Century Avenue, Nantong 226018, China.
          [3 ] School of Medicine, Nantong University, No.19 Qixiu Road, Nantong 226001, China.
          [4 ] Department of Pharmacy, Affiliated Matern &Child Care Hospital of Nantong University, No. 399 Century Avenue, Nantong 226018, China. Electronic address: fenghuang9310@163.com.
          Article
          S1567-5769(22)00918-3
          10.1016/j.intimp.2022.109433
          36371863
          1afda809-2e7f-44a5-8b25-da38fd648f21
          History

          Glabridin,Hepatic stellate cells,Inflammation,Liver fibrosis,Oxidative stress,PPARγ

          Comments

          Comment on this article